| Position | Action |
|---|---|
| Current $328 zone | 15-20% trim |
| Post-trim residual exposure | $290/$250 put spread (~3-4 month tenor) sized to ~50% of residual exposure |
| Confirmed close below $297 on volume ≥50M OR Q3 deliveries/earnings validating FCF/margin decay narrative | Additional trim deferred to catalyst-gated trigger |
| Close above $332 VWMA with MACD histogram contracting for two sessions | Skip-trim override (no additional reduction) |
Tesla is the most asymmetric risk/reward setup in megacap tech at $328, with record revenue, a fortress balance sheet, and an inflecting technical/macro setup that makes the bear's HOLD recommendation wrong given the 1:5+ risk/reward to $350-$380.
| Indicator | Value | Signal |
|---|---|---|
| 10 EMA | 325.38 | neutral |
| 50 SMA | 380.44 | bearish |
| 200 SMA | 408.80 | bearish |
| RSI (14) | 41.41 | neutral |
| MACD Line | -19.76 | bearish |
| MACD Histogram | +1.02 | bullish |
| Bollinger Lower Band | 271.11 | neutral |
| ATR (14) | 14.82 | neutral |
| Price (8/7 Close) | 328.58 | — |
| Price vs 10 EMA | +$3.20 above | bullish |
| Price vs 50 SMA | -$51.86 below | bearish |
This report is AI-generated for informational and educational purposes only and is not investment advice or a recommendation to buy or sell any security. Full disclaimer.
Underweight: 15-20% trim at $328 paired with $290/$250 put spread; defer larger reductions to catalyst gates
The Underweight thesis is dominant and unanimous across all three analysts and the Research Manager, but six consecutive Underweight decisions at structurally identical setups produced only one win (+2.2% alpha) — the smallest trim (15-20%). The execution architecture of minimal initial trim paired with a put spread avoids the alpha bleed from larger reductions (30-50%) and pure hedge-only approaches seen in prior decisions, acknowledges the dominant bear evidence through actual position reduction, addresses carry drag via the underlying reduction, preserves meaningful upside in Terafab/robotaxi surprises, defines tail risk via the put spread, and defers additional action to actual catalyst gates rather than fundamental conviction alone.
When: Post-trim residual exposure
Then: $290/$250 put spread (~3-4 month tenor) sized to ~50% of residual
Terafab ($16.8B, 3,000 jobs) makes Tesla an AI infrastructure company that solves the binding constraint of the AI economy by producing >1 terawatt of AI compute per year.
↩ rebuts: “Bear's focus on natural gas energy source being irrelevant to the compute moat thesis”
· concedes: Tesla is not a low-risk stock with a beta of 1.83 meaning 5-10% swings are normal; The bear reads financial statements correctly but interprets them incorrectly; The bear case is not contingent on a 2026 California robotaxi launch — the thesis is about 2030+ economics; 18% Polymarket robotaxi probability is not zero and shows market warming to the idea; The 2x ATR stop sits at $298.94, giving limited downside before stop
Tesla is a sell because the market prices it as an AI company while it still earns 85%+ of revenue from auto sales at 1.4% margins, with every "transformation" catalyst (Terafab, Robotaxi, Optimus) either speculative or dependent on weak partners, and technicals confirming a bearish regime with falling moving averages and negative MACD.
· concedes: Balance sheet is strong with $43.5B cash; Terafab is announced and Megapack 3 is live—catalysts are real; The narrative is exciting; Q2 net income bounced to $1.11B from Q1's $477M
→ vs conservative: One positive MACD histogram bar after eight sessions of decline is dead cat bounce, not momentum recovery; 50 SMA falling ~$3/day catches price within 2 weeks; $2.99 ATR stop at $299 is a confession of expected revisit to panic low, not tight risk management
→ vs conservative: Waiting for confirmation above $360 means waiting for 10% rally from current levels just to validate long thesis while stop is $32 below entry; asymmetry screams bear case
→ vs neutral: $43.5B cash is bankruptcy protection, not a stock thesis; does nothing to support 148x forward P/E on 1.4% operating margin business
→ vs neutral: Terafab as bull case anchor is weak: $16.8B joint venture where Tesla is minority beneficiary, SpaceX gets 3x allocation, powered by natural gas not Tesla solar, with 18% robotaxi probability in California
→ vs neutral: Neutral analyst's 'pullback to support' is exactly what the bear case is positioning for; waiting for clarity while trend is broken is the wrong framework
→ vs conservative: Sentiment of 7.5/10 is coincident indicator; price already up 4% on week; hard data (falling 50 SMA, negative MACD, 1.4% margins, exploding share count) contradicts sentiment-driven bullishness
| Price vs 200 SMA | -$80.22 below | bearish |
Support: 297.38 · 298 · 298.94 · 313.76 · 271.11 | Resistance: 333.73 · 345 · 350 · 370 · 380 · 380.44 · 408.8 · 360
TSLA is in a confirmed downtrend with all higher-timeframe moving averages (50 SMA at $380.44, 200 SMA at $408.80) declining and price significantly below both. The 10 EMA at $325.38 has been recaptured on a short-term basis, and RSI has recovered from a panic low of 25.42 to 41.41 — a textbook oversold reset. The MACD histogram just crossed positive (+1.02) for the first time in eight sessions, the earliest signal of potential momentum exhaustion, though the MACD line itself remains deeply negative at -19.76. ATR has compressed to 14.82 (from a crash peak of ~19), indicating volatility normalization and supporting tighter stop levels. The actionable trade framework calls for HOLD: longs can be probed with ATR-based stops (1× ATR = $313.76, 2× ATR = $298.94) targeting $345–$380, while positional investors should await a daily close above the falling 50 SMA (~$380) before re-engaging. Bull case triggers include a second consecutive positive MACD histogram bar, RSI above 45, and a close above $333.73 (today's high); bear case triggers include rejection at $333.73 and RSI failing at 45–50. Volume on the 8/7 rally (38.8M shares) came in below the 30-day average of ~52M, which is consistent with consolidation but does not confirm accumulation.
Market Cap
$1.298 trillion
Share Price (Implied)
~$328.65
52-Week High
$498.83
52-Week Low
$297.38
50-Day Moving Average
$388.86
200-Day Moving Average
$411.06
Trailing PE
301.45x
Forward PE
148.06x
PEG Ratio
4.71
Price/Book
14.94x
Beta
1.83
EPS (TTM)
$1.09
Forward EPS
$2.22
Revenue 2022
$81.46B
Revenue 2023
$96.77B
Revenue 2024
$97.69B
Revenue 2025
$94.83B
Revenue TTM (Q3'25–Q2'26)
$103.62B
Revenue Q1 2025
$22.50B
Revenue Q2 2025
$22.50B
Revenue Q3 2025
$28.10B
Revenue Q4 2025
$24.90B
Revenue Q1 2026
$22.39B
Revenue Q2 2026
$28.24B
Gross Margin 2022
25.6%
Gross Margin 2023
18.25%
Gross Margin 2024
17.86%
Gross Margin 2025
18.03%
Gross Margin TTM
18.85%
Operating Margin 2022
17.0%
Operating Margin 2023
9.2%
Operating Margin 2024
7.9%
Operating Margin 2025
5.1%
Operating Margin TTM
1.41%
Net Margin 2022
15.4%
Net Margin 2023
15.5%
Net Margin 2024
7.3%
Net Margin 2025
4.0%
Net Margin TTM
3.67%
Net Income 2022
$12.58B
Net Income 2023 (Peak)
$15.00B
Net Income 2024
$7.13B
Net Income 2025
$3.79B
Net Income TTM
$3.81B
Net Income Q1 2025
$1.172B
Net Income Q2 2025
$1.172B
Net Income Q3 2025
$1.373B
Net Income Q4 2025
$840M
Net Income Q1 2026
$477M
Net Income Q2 2026
$1.114B
R&D 2022
$3.08B
R&D 2025
$6.41B
R&D Q2 2026 (Quarterly Run-Rate)
~$2.4B
SG&A 2022
$3.95B
SG&A 2025
$5.83B
Stock-Based Compensation 2022
$1.56B
Stock-Based Compensation 2025
$2.825B
Stock-Based Compensation Q2 2026
$1.15B
Total Assets Q2 2026
$148.52B
Cash + ST Investments Q2 2026
$43.52B
Total Debt Q2 2026
$16.08B
Net Cash Position
~$27.4B
Total Equity Q2 2026
$87.52B
Current Ratio Q2 2026
1.94x
Working Capital Q2 2026
$33.33B
Long-Term Debt + Capital Leases Q2 2026
$13.64B
Gross PP&E Q2 2026
$84.0B
Inventory Q2 2026
$13.7B
Total Debt 2022
$5.75B
Free Cash Flow 2022
$7.55B
Free Cash Flow 2023
$4.36B
Free Cash Flow 2024
$3.58B
Free Cash Flow 2025
$6.22B
Operating Cash Flow Q1 2025
$2.54B
Operating Cash Flow Q2 2025
$2.54B
Operating Cash Flow Q3 2025
$6.24B
Operating Cash Flow Q4 2025
$3.81B
Operating Cash Flow Q1 2026
$3.94B
Operating Cash Flow Q2 2026
$4.70B
Capex Q1 2025
-$2.39B
Capex Q2 2025
-$2.39B
Capex Q3 2025
-$2.25B
Capex Q4 2025
-$2.39B
Capex Q1 2026
-$2.49B
Capex Q2 2026
-$5.80B
Free Cash Flow Q1 2025
$0.15B
Free Cash Flow Q2 2025
$0.15B
Free Cash Flow Q3 2025
$3.99B
Free Cash Flow Q4 2025
$1.42B
Free Cash Flow Q1 2026
$1.44B
Free Cash Flow Q2 2026
-$1.10B
Free Cash Flow TTM
$4.84B
Shares Outstanding Q1 2025
3.224B
Shares Outstanding Q4 2025
3.751B
Shares Outstanding Q2 2026
3.949B
Share Dilution (5 Quarters)
+22.5%
Investment Sales Q2 2026
$7.83B
End Cash Q2 2026
$16.43B
Long-Term Debt Issued Q1 2026
$4.33B
Long-Term Debt Repaid Q1 2026
$3.55B
Long-Term Debt Issued Q2 2026
$348M
Long-Term Debt Repaid Q2 2026
$411M
ROE TTM
4.67%
ROA TTM
1.93%
SBC TTM Run-Rate
~$4.3B
Share Buybacks
None
Dividends
None
Strengths
Concerns
Tesla presents a high-risk, high-reward profile at an inflection point: record Q2 2026 revenue ($28.24B) and a fortress balance sheet ($43.5B liquidity, $27.4B net cash) demonstrate fundamental quality, while operating margin has collapsed to 1.41% and net income is down 75% from its 2023 peak due to exploding opex (R&D +50% YoY, SBC ~$4.3B annualized). The stock trades near 52-week lows (~34% below 50-day MA, ~20% below 200-day MA) with extreme valuation (PE 301x trailing, 148x forward), and aggressive AI/robotics capex ($5.8B in Q2 alone) drove FCF negative while providing asymmetric upside optionality if Robotaxi/Optimus succeed. HOLD rating reflects fortress balance sheet preventing a sell call, but extreme valuation, margin compression, and share dilution warrant new capital to await margin recovery or pullback to technical support near the 52-week low ($297).